ArticleOrphanet journal of rare diseases2025
Measuring economic burden in families of individuals with Angelman Syndrome in Poland: a caregivers' survey.
Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAngelman Syndrome (AS) is a rare neurogenetic disorder characterized by severe intellectual disability, seizures, and motor and speech impairments, requiring lifelong, intensive care. Although caregivers of individuals with AS often face reduced quality of life and substantial emotional and financial strain, little is known about the cost-of-illness in Poland. To address this gap, we conducted a cross-sectional study in collaboration with the Foundation for Angelman Syndrome Therapeutics Poland (FAST Poland). An anonymous web-based survey was completed by 85 parents of individuals with AS to assess the 12-month financial burden of caregiving, including healthcare utilization, non-medical expenses, caregiver-related health costs, and broader socioeconomic impacts.
resultsThe average annual out-of-pocket cost per household was $69,511, which far exceeded the average public reimbursement of $46,928. Major private expenditures included therapy and rehabilitation ($7,836), non-reimbursed rehabilitation camps ($4,451), and medical equipment ($2,637). Income loss due to caregiving averaged $31,809 per household, contributing significantly to the overall burden. Psychological support and medication for caregivers generated additional costs, often paid entirely out of pocket. Spearman’s correlations revealed that younger patients incurred higher hospitalization and private rehabilitation expenses, while older individuals required more home modifications. Caregiving averaged 89.4 h per week, with minimal professional or informal assistance. Despite most families receiving public support, it did not offset the full economic impact, particularly indirect costs such as reduced employment. The findings underscore the chronic, high-cost nature of AS caregiving in Poland, marked by insufficient systemic support and reliance on family-provided, unpaid care.
conclusionAS imposes a major financial burden on families, as out-of-pocket expenses and income loss surpass public aid. These findings underscore the urgent need for improved systemic and policy-level support for caregiving.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.